Cochrane · systematic review · CD012605
Radical multimodality therapy for malignant pleural mesothelioma
Abdel‐Rahman, O, Elsayed, Z, Mohamed, H, et al. · Cochrane Database of Systematic Reviews · 2018 · Cochrane Library
Lung CancerAMSTAR 2: not assessed
SoF tableOnly the outcomes this review put in its Summary of Findings table are listed (the Cochrane Handbook caps them at about seven per comparison). Its other analyses are not shown here.
Questions
10
current version
GRADE rated
10
No studies
0
Included studies
NR
No studies 0 · 0%Ungraded 0 · 0%Very low 0 · 0%Low 8 · 80%Moderate 2 · 20%High 0 · 0%
Ungraded means an effect was reported without a GRADE rating; it is not a gap. No studies means the review found nothing to answer the question. The six categories are a display order, not a score.
Questions and results
Comparison
Population: people with malignant pleural mesothelioma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Median overall survival | no estimate extracted | 1 study · 54 participants | Moderate Downgraded: imprecision |
Health‐related health‐related quality of life | no estimate extracted | 1 study · 54 participants | Low Downgraded: risk of bias, imprecision |
Adverse events | no estimate extracted | 1 study · 54 participants | Low Downgraded: risk of bias, imprecision |
Postoperative complications | no estimate extracted | 1 study · 54 participants | Low Downgraded: risk of bias, imprecision |
Treatment‐related death | no estimate extracted | 1 study · 54 participants | Low Downgraded: risk of bias, imprecision |
Comparison
Population: people with malignant pleural mesothelioma
| Outcome | Effect | Evidence | Status / GRADE |
|---|---|---|---|
Median overall survival | no estimate extracted | 1 study · 50 participants | Moderate Downgraded: imprecision |
Health‐related health‐related quality of life | no estimate extracted | 1 study · 50 participants | Low Downgraded: risk of bias, imprecision |
Adverse events | no estimate extracted | 1 study · 50 participants | Low Downgraded: risk of bias, imprecision |
Progression‐free survival | no estimate extracted | 1 study · 50 participants | Low Downgraded: risk of bias, imprecision |
Treatment‐related death | no estimate extracted | 1 study · 50 participants | Low Downgraded: risk of bias, imprecision |